Diabetomics Medical Profile
Key Indicators
- Authorised Capital ₹ 1.01 Cr
- Paid Up Capital ₹ 2.90 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.00 Cr
- Revenue Growth 11.39%
- Profit Growth -42.93%
- Ebitda -29.06%
- Net Worth -0.99%
- Total Assets -6.02%
About Diabetomics Medical
Diabetomics Medical Private Limited (DMPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 June 2015 (Nine years and seven months 18 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 2.90 M.
The company has closed loans amounting to ₹5.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anshuman Jaiswal, Koduru Reddy, Ramadhara Kancharla, and Two other members serve as directors at the Company.
Company Details
-
Location
Medak, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233TG2015PTC099351
-
Company No.
099351
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jun 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Diabetomics Medical?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshuman Jaiswal
|
Director | 14-May-2024 | Current |
|
Koduru Reddy
|
Director | 16-Jun-2015 | Current |
|
Ramadhara Kancharla
|
Director | 14-May-2024 | Current |
|
Yalamanchili Rao
|
Director | 16-Jun-2015 | Current |
Srinivasa Nagalla
|
Director | 10-Sep-2015 | Current |
Financial Performance of Diabetomics Medical.
Diabetomics Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.39% increase. The company also saw a substantial fall in profitability, with a 42.93% decrease in profit. The company's net worth dipped by a decrease of 0.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diabetomics Medical?
In 2023, Diabetomics Medical had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Yalamanchi Hospitals And Research Centres Pvt LtdYalamanchili Rao is a mutual person
-
Ahlada Engineers LimitedKoduru Reddy is a mutual person
-
Gcbc Vaccines Private LimitedKoduru Reddy is a mutual person
-
Svas Investments Private Limited
Koduru Reddy is a mutual person
-
Sesha Sarojini Projeckts Llp
Ramadhara Kancharla is a mutual person
-
Sesha Sarojini Medical Infra Private Limited
Ramadhara Kancharla is a mutual person
Charges (Loans)
₹0
₹5.00 Cr
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Others | ₹5.00 Cr | Satisfied |
How Many Employees Work at Diabetomics Medical?
Diabetomics Medical has a workforce of 38 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diabetomics Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diabetomics Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
